KarenAGrahamMD

Medical Director, Outreach And Support Intervention Services (OASIS), Professor of Psychiatry, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Graham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Graham's full profile

Already have an account?

Office
77 Vilcom Center Dr. Dawson Hall
Suite 300
Chapel Hill, NC 27514
Phone+1 919-962-1401

Fax+1 919-962-7373

Education & Training

University of Arizona College of Medicine-PhoenixFellowship, Integrative Medicine, 2016 - 2018
University of North Carolina HospitalsResidency, Psychiatry, 1998 - 2000
McMaster University Medical SchoolPsychiatry, 1990 - 1993
Michael G. DeGroote School of MedicineClass of 1993

Certifications & Licensure

NC State Medical License 1998 - 2025
VA State Medical License 1999 - 2002
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Study of Amantadine for Weight Stabilization During Olanzapine Treatment Start of enrollment: 2005 May 01
Completed
Phase 1
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine Start of enrollment: 2005 Aug 01
Completed

Publications & Presentations

PubMed

57 citations
Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia
Karen A. Graham, Richard S.E. Keefe, Jeffrey A. Lieberman, A.S. Calikoglu, K.M. Lansing
Early Intervention in Psychiatry. 2015-10-01
15 citations
A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
Anne C. Kelly, Brian Sheitman, Robert M. Hamer, David C. Rhyne, Robin M. Reed
Journal of Clinical Psychopharmacology. 2014-08-01
61 citations
Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial
Richard S.E. Keefe, Sophia Vinogradov, Alice Medalia, Peter F. Buckley, Stanley N. Caroff
The Journal of Clinical Psychiatry. 2012-05-15

Grant Support

Investigation Of BMI, Etc Changes Following A Switch From OlanzapineNational Center For Research Resources2006–2008
Amantadine For Prevention Of Weight GAIN In First Epidsode Adult Psychotic SubjNational Center For Research Resources2006–2008
Weight GAIN With Olanzapine, Quetiapine And Risperidone In Subjects With PsychosNational Center For Research Resources2004–2006